U.S. President Donald Trump has put his faith in anti-malarial drug hydroxychloroquine to ward off COVID-19, but governments and investors are focusing on a vaccine. Without one, it’s unlikely economic activity can resume fully.
(Bloomberg) — The antimalaria drugs that U.S. President Donald Trump has touted to fight Covid-19 are linked to an increase of death and heart ailments.Oxford University and AstraZeneca started recruiting subjects for advanced human studies of one of the fastest-moving experimental vaccines. Anthony Fauci, who is leading the U.S. infectious disease control effort, said he was “cautiously optimistic” about Moderna’s vaccine, boosting the stock.Brazil had another record day of deaths and its government agreed to the terms of a financial aid package. Beijing abandoned a growth target for 2020 amid the uncertainty caused by the coronavirus, while central banks in …read more […]
NexTech’s 3D/AR Ad Network Poised to Transform $240 Billion Dollar Global Ad Industry NEW YORK, May 22, May 22, 2020 (GLOBE NEWSWIRE via COMTEX) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
Stocks edged down Friday morning as ongoing signs of the economic damage from the coronavirus pandemic compounded with fears of rising U.S.-China tensions. A slew of quarterly corporate earnings results came in mixed. …read more […]
U.S. stocks opened flat on Friday as investors pitted hopes of more stimulus to revive an ailing economy against deteriorating U.S.-China relations over Beijing’s move to impose a national-security law in Hong Kong.
(This May 19 story officially corrects paragraph 3 to say net loss of “$3.52” per share and not “$3.50” after company adjusts the number while preparing its quarterly filing.)
Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Anjalee Khemlani discuss the latest coronavirus news and the race for a vaccine. …read more […]
Alibaba Group Holding Ltd on Friday reported forecast-beating fourth-quarter revenues and profits, as more people shopped online for essentials because of the coronavirus lockdowns.
U.S. stock indexes were set for a near-flat open on Friday as investors weighed hopes of more stimulus to revive an ailing economy against simmering Sino-U.S. trade tensions.
Chinese technology company NetEase plans to carry out a secondary listing on the Hong Kong Stock Exchange on June 11, which will be followed one week later by web retailer JD.com , four sources with direct knowledge of the matter said.
Dividend paying stocks like Momo Inc. (NASDAQ:MOMO) tend to be popular with investors, and for good reason – some… …read more […]
A SelectQuote IPO is coming to the markets. Since November 2019, the company filed registration statements and amendments. Now, investors want to know when to expect SelectQuote stock.
But more importantly, is SelectQuote a good investment? Here’s what we know…
SelectQuote IPO: The Business
Charan Singh founded SelectQuote in 1984. Singh currently serves as a chairman. Tim Danker has been the CEO since 2017. The Kansas-based company provides an online platform to compare insurance policies for life, home and auto. SelectQuote doesn’t insure the consumer directly. Instead, the company works with over 50 carriers to choose from.
In late March, SelectQuote announced it will …read more […]
Qualcomm (QCOM) is positioned close to the eye of the macro storm. A heavy reliance on China and uncertainty concerning near-term smartphone supply and demand dynamics have contributed to a difficult 2020 for QCOM, with shares down 12% year-to-date. However, despite renewed tensions between the U.S. and China, Qualcomm could actually benefit from the worrying developments, so says Canaccord Genuity analyst Michael Walkley. The recent Department of Commerce ban on Huawei, preventing it from purchasing semiconductors from U.S. companies, has ignited fears of retaliatory moves against companies such as Apple and Qualcomm. That being said, Qualcomm’s management noted Huawei is …read more […]
Talks over a 9-billion euro German government bailout of Lufthansa have hit a snag and will continue over the weekend, a German newspaper reported on Friday.
Chinese e-commerce and digital tech giant Alibaba delivered better than expected results for the financial year to March 2020. Revenue grew by 35% to $72 billion (RMB509 billion). Net profits grew 42% to $19.8 billion, or $18.7 billion when expressed in non-GAAP form. Alibaba’s digital media and entertainment segment accounted for losses of $1.57 billion […] …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
